Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Michonneau

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
The Journal of Investigative Dermatology|May 20, 2020
Expansion of Circulating CD49b<sup>+</sup>LAG3<sup>+</sup> Type 1 Regulatory T Cells in Human Chronic Graft-Versus-Host DiseaseNana Talvard-Balland, Aurélien Sutra Del Galy, David Michonneau, et al.
Haematologica|March 23, 2023
Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experienceGerard Socie, Jacques-Emmanuel Galimard, Emmanuel Raffoux, et al.
Cancer|October 24, 2018
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working PartyAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
Blood Advances|January 28, 2026
Pregnancy after Haematopoietic Stem Cell Transplant: an international multicentre studyNina Salooja, Dirk-Jan Eikema, David Michonneau, et al.
Bone Marrow Transplantation|March 28, 2026
Clinical outcomes of third-line therapy for aGvHD with gastrointestinal involvement after steroids and ruxolitinib failureJohannes Clausen, José Antonio Pérez Simón, Martin Carré, et al.
Bone Marrow Transplantation|March 26, 2021
Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groupsMarie Robin, Raphael Porcher, Corentin Orvain, et al.
American Journal of Respiratory and Critical Care Medicine|June 26, 2025
Addressing Knowledge Gaps in the Early Detection of Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation: An Official American Thoracic Society Research StatementGuang-Shing Cheng, Ajay Sheshadri, Jane Turner, et al.
Blood Advances|January 10, 2022
RNA sequencing of chronic GVHD skin lesions defines shared and unique inflammatory pathways characterizing lichen planus and morpheaHabib Zouali, Juliette Lemasson, Andreea Calugareanu, et al.
Haematologica|June 13, 2024
PD-1 blockade and allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma, a matter of time: a national study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie CellulaireEleonore Kaphan, Francois Bettega, Nicolas Vallet, et al.
Blood Advances|March 31, 2025
AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signalingAlexander Zähringer, Inês Morgado, Daniel Erny, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Investigative Dermatology|May 20, 2020
Expansion of Circulating CD49b<sup>+</sup>LAG3<sup>+</sup> Type 1 Regulatory T Cells in Human Chronic Graft-Versus-Host DiseaseNana Talvard-Balland, Aurélien Sutra Del Galy, David Michonneau, et al.
Haematologica|March 23, 2023
Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experienceGerard Socie, Jacques-Emmanuel Galimard, Emmanuel Raffoux, et al.
Cancer|October 24, 2018
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working PartyAli Bazarbachi, Ariane Boumendil, Hervé Finel, et al.
Blood Advances|January 28, 2026
Pregnancy after Haematopoietic Stem Cell Transplant: an international multicentre studyNina Salooja, Dirk-Jan Eikema, David Michonneau, et al.
Bone Marrow Transplantation|March 28, 2026
Clinical outcomes of third-line therapy for aGvHD with gastrointestinal involvement after steroids and ruxolitinib failureJohannes Clausen, José Antonio Pérez Simón, Martin Carré, et al.
Bone Marrow Transplantation|March 26, 2021
Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groupsMarie Robin, Raphael Porcher, Corentin Orvain, et al.
American Journal of Respiratory and Critical Care Medicine|June 26, 2025
Addressing Knowledge Gaps in the Early Detection of Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation: An Official American Thoracic Society Research StatementGuang-Shing Cheng, Ajay Sheshadri, Jane Turner, et al.
Blood Advances|January 10, 2022
RNA sequencing of chronic GVHD skin lesions defines shared and unique inflammatory pathways characterizing lichen planus and morpheaHabib Zouali, Juliette Lemasson, Andreea Calugareanu, et al.
Haematologica|June 13, 2024
PD-1 blockade and allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma, a matter of time: a national study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie CellulaireEleonore Kaphan, Francois Bettega, Nicolas Vallet, et al.
Blood Advances|March 31, 2025
AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signalingAlexander Zähringer, Inês Morgado, Daniel Erny, et al.
Pageof 11